Skip to content

MRNA

Moderna, Inc.

Income statement

Income statement
Line, in USDLast 12 months2025202420232022202120202019201820172016
Revenue2.5B1.9B3.2B6.8B19.3B18.5B803M60M135M206M108M
Cost of revenue
1.82B0.87B1.46B4.69B5.42B2.62B8.0M00——
Gross profit707M1.1B1.8B2.2B13.8B15.9B795M60M135M——
2.66B3.13B4.54B4.85B3.30B1.99B1.37B0.50B0.45B0.41B0.27B
Other operating expenses
0.98B1.02B1.17B1.55B1.13B0.57B0.19B0.11B94M——
Operating income−2.9B−3.1B−3.9B−4.2B9.4B13.3B−763M−546M−413M−269M−224M
Non-operating income
201M306M338M297M155M−11M19M31M29M13M8.6M
Pretax income−2.7B−2.8B−3.6B−3.9B9.6B13.3B−744M−515M−384M−256M−215M
Taxes
60M54M−46M0.77B1.21B1.08B3.0M−1.0M326K−80K1.0M
Net income−2.8B−2.8B−3.6B−4.7B8.4B12.2B−747M−514M−385M−256M−216M
Diluted EPS−7.10−7.26−9.28−12.3320.1228.29−1.96−1.55−4.95−4.18−3.79
Diluted shares—389.0M384.0M382.0M416.0M431.0M381.0M331.0M81.1M64.5M60.7M
Revenue growth—−39.9%−52.7%−64.4%+4.3%+2,200.2%+1,238.3%−55.6%−34.4%+89.9%—
Gross margin28.0%55.3%54.8%31.5%71.9%85.8%99.0%100.0%100.0%——
Operating margin−116.0%−158.1%−121.9%−61.9%48.9%72.0%−95.0%−910.0%−306.0%−130.9%−206.4%
Net margin−110.5%−145.2%−110.0%−68.8%43.4%66.1%−93.0%−856.7%−284.8%−124.3%−199.5%